FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

38931411000001105: Bempedoic acid 180mg / Ezetimibe 10mg tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Sep 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1586001000001118 Bempedoic acid 180mg / Ezetimibe 10mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1586021000001113 Bempedoic acid 180mg / Ezetimibe 10mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bempedoic acid 180mg / Ezetimibe 10mg tablets Is a Bempedoic + Ezetimibe true Inferred relationship Existential restriction modifier
Bempedoic acid 180mg / Ezetimibe 10mg tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Bempedoic acid 180mg / Ezetimibe 10mg tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Bempedoic acid 180mg / Ezetimibe 10mg tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Bempedoic acid 180mg / Ezetimibe 10mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Bempedoic acid 180mg / Ezetimibe 10mg tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Bempedoic acid 180mg / Ezetimibe 10mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Bempedoic acid 180mg / Ezetimibe 10mg tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Bempedoic acid 180mg / Ezetimibe 10mg tablets Has specific active ingredient Ezetimibe true Inferred relationship Existential restriction modifier
Bempedoic acid 180mg / Ezetimibe 10mg tablets Is a Bempedoic + Ezetimibe false Inferred relationship Existential restriction modifier
Bempedoic acid 180mg / Ezetimibe 10mg tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Bempedoic acid 180mg / Ezetimibe 10mg tablets Has specific active ingredient Bempedoic acid false Inferred relationship Existential restriction modifier
Bempedoic acid 180mg / Ezetimibe 10mg tablets Has specific active ingredient Bempedoic acid true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Bempedoic acid 180mg / Ezetimibe 10mg tablets 28 tablet Has VMP True Bempedoic acid 180mg / Ezetimibe 10mg tablets Inferred relationship Existential restriction modifier
Nustendi 180mg/10mg tablets (Daiichi Sankyo UK Ltd) Is a True Bempedoic acid 180mg / Ezetimibe 10mg tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start